New England Biolabs' NEBNext Direct Cancer HotSpot Panel

New England Biolabs, or NEB, has launched the NEBNext Direct Cancer HotSpot Panel. The new panel incorporates a novel targeted enrichment technology for next-generation sequencing, NEBNext Direct, that was developed in collaboration with Directed Genomics, the company said. The new technology leverages NEB's deep expertise in enzymology to maximize yields and minimize errors that can be introduced during sample preparation. The Cancer HotSpot panel combines the strength of both PCR amplicon and hybridization based approaches to employ a single tube, single day workflow that combines enrichment with library preparation. It enriches critical regions within 50 commonly studied genes known to be associated with cancer.